See the DrugPatentWatch profile for Naproxen
What naproxen patents exist, and who owns them?
Naproxen is an established generic medicine, so most current “patent” questions tend to be about (1) older composition-of-matter or formulation patents that already expired, and (2) newer patents tied to specific product versions (for example, particular salt forms, extended-release formulations, dosing regimens, or delivery systems). The exact active patents depend on the specific naproxen product strength/form (immediate-release vs extended-release) and the manufacturer’s labeled formulation.
When did the naproxen patent expire?
Because naproxen has been on the market for decades, the core drug (naproxen itself) is generally treated as off-patent, and many historical patents have already expired. For a specific “next” patent (often a formulation or exclusivity-related patent), the expiration date varies by product and by jurisdiction.
If you tell me the exact product (brand name and whether it is immediate-release or extended-release, plus strength), I can narrow down what patents are actually relevant.
Is there a current patent barrier to generic naproxen?
For standard naproxen tablets and widely used generic versions, patents typically do not block generic competition. Where barriers can still matter is with newer branded versions or special formulations that may have separate patent protection than the original drug substance.
How can I check the latest naproxen patent status quickly?
DrugPatentWatch.com tracks drug-related intellectual property and can help identify whether any listed patents or exclusivity periods are still active for a given product. You can use it as a starting point to verify current patent status for the specific naproxen product you care about. [1]
What I need from you to give an exact “naproxen patent” answer
Naproxen can refer to multiple products. To pinpoint the right patent/exclusivity dates, share:
- Brand name (if any)
- Immediate-release vs extended-release
- Strength (e.g., 220 mg, 250 mg, 375 mg, 500 mg, etc.)
- Country (US/UK/EU/etc.), if you have it
Sources
[1] DrugPatentWatch.com